Skip to content

CorMedix Inc.

CRMD· NasdaqCore metricsCIK 1410098

Pharmaceutical preparations552 peers

Last sale
Nov 2, 2026 · -5.53%
Market cap
$427.59M
79.48M shares
Filings
1,024
$54.52M
Q3 2026+617.0% FY25 yoy
-$14.72M
Q3 2026N/M FY25 yoy
-$6.62M
Q3 2026N/M FY25 yoy
$215.12M
Q3 2026derivedN/M FY25 yoy
-$0.19
Q3 2026N/M FY25 yoy
$355.15M
Q3 2026+256.3% FY25 yoy
$427.59M
6.7×
1.0×
0.9×
72.00%
—

Twelve months to Sep 30, 2026 · derived

Price

$5.3853.38%$6.16past year
Nov 2, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$311.71MFY 2025
$311.71M0FY 2013FY 2018FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$311,709,000reported
FY 20242024-12-31$43,472,000reported
FY 20222022-12-31$65,408reported
FY 20212021-12-31$190,936reported
FY 20202020-12-31$239,231reported
FY 20192019-12-31$283,266reported
FY 20182018-12-31$429,797reported
FY 20172017-12-31$329,327reported
FY 20162016-12-31$224,105reported
FY 20152015-12-31$210,130reported
FY 20142014-12-31$189,274reported
FY 20132013-12-31$2,001reported

Segments

Assets by Geography, FY2019 to FY2021FY2019US · FY2019 · $28.92MFY2020United States · FY2020 · $48.93MUS · FY2020 · $48.93MFY2021United States · FY2021 · $68.56M
LineFY2021ShareChange
United States$68.56M99%+40.1%
US———
Total$68.95M

From the 10-K filed Mar 29, 2022CRMD

Pharmaceutical preparations

CorMedix Inc. is the 66th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

CorMedix Inc. · CIK 1410098 · Engraved from SEC EDGAR